Theralase Technologies Inc. Stock Toronto S.E.
Equities
TLT
CA88337V1004
Advanced Medical Equipment & Technology
Sales 2024 * | 1.65M 1.21M | Sales 2025 * | 2.28M 1.67M | Capitalization | 38.8M 28.33M |
---|---|---|---|---|---|
Net income 2024 * | -4M -2.92M | Net income 2025 * | -5M -3.65M | EV / Sales 2024 * | 23.5 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 17 x |
P/E ratio 2024 * |
-8.25
x | P/E ratio 2025 * |
-8.25
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.72% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 89-08-21 | |
Kristina Hachey
DFI | Director of Finance/CFO | - | 19-06-26 |
Arkady Mandel
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 89-08-21 | |
Kristina Hachey
DFI | Director of Finance/CFO | - | 19-06-26 |
Randy Bruder
BRD | Director/Board Member | - | 07-12-31 |
1st Jan change | Capi. | |
---|---|---|
+16.92% | 975M | |
-38.40% | 194M | |
-36.43% | 73.69M |